San Francisco-based Feel Therapeutics offers both a monitoring and measuring tool and a DTx platform. It uses a proprietary emotion sensor, in the form of a wristband, to monitor a user’s emotional state and delivers practical advice, tools, exercises, and resources via its mobile app to deal with changes detected by the sensor. Additionally, users have access to mental healthcare providers for online sessions included in the program.
The company operates both a B2B2C model and D2C business model. As of June 2022, the platform is available to user groups across the US and Europe and it offers two programs: the Feel Program which is a 16 weeks program (to support mental health patients) available only via insurance providers and pharmaceutical companies; and the Feel Relief Program (to reduce stress, promote sleep, and improve emotional wellbeing) which is a 4 week program available to individuals to purchase online for USD 50 per week.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.